64 reports

  • Cystic Fibrosis Products
  • Cystic Fibrosis Products
  • Cystic Fibrosis
  • World
  • Market Size
  • AbbVie Inc.
  • Editas Medicine, Inc.
  • SNAPSHOT OF CYSTIC FIBROSIS
  • DIAGNOSIS OF CYSTIC FIBROSIS
  • Cystic Fibrosis
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Novartis AG
  • 2.5.4 CYSTIC FIBROSIS
  • 2.6.4 CYSTIC FIBROSIS
  • Cystic Fibrosis
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • 2.6.4 CYSTIC FIBROSIS
  • Source: GlobalData, Proprietary Deals Database
  • Cystic Fibrosis
  • World
  • Market Size
  • AstraZeneca PLC
  • GlaxoSmithKline plc

Cystic Fibrosis: An Overview ##.

  • Cystic Fibrosis
  • Pathology
  • World
  • Market Size
  • CYSTIC FIBROSIS
  • CYSTIC FIBROSIS
  • Cystic Fibrosis
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Cystic Fibrosis Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Cystic Fibrosis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Cystic Fibrosis pipeline products, Cystic Fibrosis epidemi

  • Cystic Fibrosis
  • France
  • Germany
  • Italy
  • Market Size
  • 5.2.2.2.3 CYSTIC FIBROSIS
  • Middle East and Africa Genetic testing Market by Disease-Cystic Fibrosis-
  • Cystic Fibrosis
  • World
  • Forecast
  • Biocartis S.A.
  • Transgenomic, Inc.

Key Features of the Report: - Cystic Fibrosis: Disease Definition - Cystic Fibrosis Patient Flow - Cystic Fibrosis Prevalence - Cystic Fibrosis Diagnosed Patients - Cystic Fibrosis Treated Patients

  • Cystic Fibrosis
  • Pathology
  • Europe
  • World
  • Forecast
  • EMILY DIMANGO, MD
  • STUART JOSEPH ELBORN, MD
  • Cystic Fibrosis
  • Canada
  • France
  • Italy
  • Forecast

Qualitative Analysis of the Cystic Fibrosis Market ##. ## Strengths of the Cystic Fibrosis Market ##. ## Weaknesses of the Cystic Fibrosis Market ##. ## Opportunities for the Cystic Fibrosis Market ##. ## Threats for the Cystic Fibrosis Market ##. ## Political Factors I

  • Cystic Fibrosis
  • Pathology
  • United States
  • Forecast
  • Market Size
  • Mar 23, 2016: Toward Personalized Medicine for Patients with Cystic Fibrosis
  • Mar 23, 2016: Toward Personalized Medicine for Patients with Cystic Fibrosis
  • Cystic Fibrosis
  • Healthcare
  • Therapy
  • United States
  • GlobalData's company
  • Snapshot of Cystic Fibrosis
  • 07.5 Manifestations of Cystic Fibrosis
  • Cystic Fibrosis
  • Europe
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.

Cystic Fibrosis Therapeutics Market Variables, Trends & Scope ##. ##.

  • Cystic Fibrosis
  • Pathology
  • Forecast
  • 2 Cystic Fibrosis: Executive Summary
  • CYSTIC FIBROSIS: KEY METRICS IN THE SEVEN MAJOR PHARMACEUTICAL MARKETS
  • Cystic Fibrosis
  • Forest Laboratories, Inc.
  • Novartis AG
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Japan Cystic Fibrosis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cystic Fibrosis Treatments ##) Cystic Fibrosis Pipeline ##) Japan Cystic Fibrosis Epidemiology ##) Marketed Drugs for

  • Cystic Fibrosis
  • Pathology
  • Japan
  • Market Size

Cystic Fibrosis Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Cystic Fibrosis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Cystic Fibrosis pipeline products, Cystic Fibrosis epidemiolo

  • Cystic Fibrosis
  • Europe
  • France
  • Germany
  • Market Size

Germany Cystic Fibrosis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cystic Fibrosis Treatments ##) Cystic Fibrosis Pipeline ##) Germany Cystic Fibrosis Epidemiology ##) Marketed Drugs for

  • Cystic Fibrosis
  • Pathology
  • Germany
  • Market Size

Italy Cystic Fibrosis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cystic Fibrosis Treatments ##) Cystic Fibrosis Pipeline ##) Italy Cystic Fibrosis Epidemiology ##) Marketed Drugs for

  • Cystic Fibrosis
  • Pathology
  • Italy
  • Market Size

France Cystic Fibrosis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cystic Fibrosis Treatments ##) Cystic Fibrosis Pipeline ##) France Cystic Fibrosis Epidemiology ##) Marketed Drugs for

  • Cystic Fibrosis
  • Pathology
  • France
  • Market Size

UK Cystic Fibrosis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cystic Fibrosis Treatments ##) Cystic Fibrosis Pipeline ##) UK Cystic Fibrosis Epidemiology ##) Marketed Drugs for

  • Cystic Fibrosis
  • Pathology
  • United Kingdom
  • Market Size

US Cystic Fibrosis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cystic Fibrosis Treatments ##) Cystic Fibrosis Pipeline ##) US Cystic Fibrosis Epidemiology ##) Marketed Drugs for

  • Cystic Fibrosis
  • Pathology
  • Market Size

Spain Cystic Fibrosis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cystic Fibrosis Treatments ##) Cystic Fibrosis Pipeline ##) Spain Cystic Fibrosis Epidemiology ##) Marketed Drugs for

  • Cystic Fibrosis
  • Pathology
  • Spain
  • Market Size

MARKET OVERVIEW.............. ## Cystic Fibrosis (CF) Patient Population ## Table ##: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2014) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA ## Table ##: Molecular Diagnost

  • Cystic Fibrosis
  • Erythropoietin
  • China
  • World
  • Demand

Cystic Fibrosis (CF) Patient Population ## Table ##: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2014) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA ## Table ##: Molecular Diagnostic Genetics Laboratories Mar

  • Cancer
  • Cystic Fibrosis
  • United States
  • World
  • Market Shares
  • CYSTIC FIBROSIS FOUNDATION THERAPEUTICS ENTERS INTO RESEARCH AGREEMENT WITH PFIZER FOR CYSTIC FIBROSIS DRUGS
  • CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC, OTHER LOCATIONS
  • Cystic Fibrosis
  • Pharmaceutical
  • United States
  • Company
  • Cystic Fibrosis Foundation Therapeutics, Inc.
  • Cystic Fibrosis Foundation have conducted highest number of cystic fibrosis clinical trials.
  • LATEST CLINICAL TRIALS NEWS ON CYSTIC FIBROSIS
  • Anti-Infective
  • Cystic Fibrosis
  • United States
  • World
  • Cystic Fibrosis Foundation Therapeutics, Inc.
  • MAY 03, 2016: CELTAXSYS BEGINS EU ENROLLMENT FOR CF LUNG FUNCTION PRESERVATION TRIAL OF ACEBILUSTAT ANTI- INFLAMMATORY THERAPY FOR CYSTIC FIBROSIS
  • OCT 08, 2015: CELTAXSYS BEGINS US ENROLLMENT FOR PHASE 2 TRIAL OF ACEBILUSTAT ANTI-INFLAMMATORY THERAPY FOR CYSTIC FIBROSIS
  • Cystic Fibrosis
  • Therapy
  • United States
  • Product Initiative
  • Celtaxsys, Inc.
  • PROQR THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH CYSTIC FIBROSIS FOUNDATION
  • JUL 19, 2016: PROQR RECEIVES FAST TRACK DESIGNATION FROM FDA FOR QR-010 FOR CYSTIC FIBROSIS
  • Cystic Fibrosis
  • Genomics
  • United States
  • Company
  • ProQR Therapeutics N.V.
  • Sep 04, 2014: FDA Grants Fast Track Designation to Aradigm's Pulmaquin for Non-Cystic Fibrosis Bronchiectasis
  • Sep 15, 2017: Aradigm to Host KOL Call on Infection Management in Non-Cystic Fibrosis Bronchiectasis Patients
  • Cystic Fibrosis
  • Respiratory Disease
  • United States
  • Product Initiative
  • Pulmaquin group